Latest Insider Transactions at Imago Bio Sciences, Inc. (IMGO)
This section provides a real-time view of insider transactions for Imago Bio Sciences, Inc. (IMGO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Imago BioSciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Imago BioSciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 20
2022
|
Laura G. Eichorn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,000
-0.48%
|
$18,000
$18.0 P/Share
|
|
Jul 20
2022
|
Laura G. Eichorn Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.48%
|
$2,000
$2.52 P/Share
|
|
Jul 18
2022
|
Wan Jen Hong Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+50.0%
|
$7,000
$7.06 P/Share
|
|
Mar 30
2022
|
Clarus Lifesciences Iii, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
1,000,000
-29.63%
|
-
|
|
Feb 22
2022
|
Laura G. Eichorn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,000
-1.86%
|
$168,000
$21.87 P/Share
|
|
Feb 22
2022
|
Laura G. Eichorn Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+3.58%
|
$16,000
$2.52 P/Share
|
|
Feb 11
2022
|
Amy E. Tapper Chief, Technical Operations |
SELL
Open market or private sale
|
Direct |
3,000
-2.46%
|
$69,000
$23.78 P/Share
|
|
Feb 11
2022
|
Amy E. Tapper Chief, Technical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+2.4%
|
$3,000
$1.52 P/Share
|
|
Feb 11
2022
|
Laura G. Eichorn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,000
-1.89%
|
$92,000
$23.61 P/Share
|
|
Feb 11
2022
|
Laura G. Eichorn Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+1.85%
|
$4,000
$1.52 P/Share
|
|
Feb 11
2022
|
Jennifer Peppe Officer |
SELL
Open market or private sale
|
Direct |
7,000
-4.49%
|
$161,000
$23.76 P/Share
|
|
Feb 11
2022
|
Jennifer Peppe Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+4.3%
|
$14,000
$2.1 P/Share
|
|
Feb 09
2022
|
Amy E. Tapper Chief, Technical Operations |
SELL
Open market or private sale
|
Direct |
3,000
-2.46%
|
$63,000
$21.54 P/Share
|
|
Feb 09
2022
|
Amy E. Tapper Chief, Technical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+2.4%
|
$3,000
$1.52 P/Share
|
|
Feb 09
2022
|
Laura G. Eichorn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,000
-1.89%
|
$84,000
$21.56 P/Share
|
|
Feb 09
2022
|
Laura G. Eichorn Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+1.85%
|
$4,000
$1.52 P/Share
|
|
Feb 09
2022
|
Jennifer Peppe Officer |
SELL
Open market or private sale
|
Direct |
10,000
-6.3%
|
$220,000
$22.26 P/Share
|
|
Feb 09
2022
|
Jennifer Peppe Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.07%
|
$20,000
$2.05 P/Share
|
|
Feb 07
2022
|
Jennifer Peppe Officer |
SELL
Open market or private sale
|
Direct |
13,000
-4.1%
|
$260,000
$20.51 P/Share
|
|
Feb 07
2022
|
Jennifer Peppe Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,000
+3.94%
|
$26,000
$2.02 P/Share
|
|
Feb 01
2022
|
Amy E. Tapper Chief, Technical Operations |
SELL
Open market or private sale
|
Direct |
6,500
-2.6%
|
$123,500
$19.98 P/Share
|
|
Feb 01
2022
|
Amy E. Tapper Chief, Technical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+4.92%
|
$13,000
$2.1 P/Share
|
|
Jan 12
2022
|
Laura G. Eichorn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,000
-3.71%
|
$152,000
$19.96 P/Share
|
|
Jan 12
2022
|
Laura G. Eichorn Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+3.58%
|
$8,000
$1.52 P/Share
|
|
Jan 12
2022
|
Amy E. Tapper Chief, Technical Operations |
SELL
Open market or private sale
|
Direct |
6,000
-4.8%
|
$114,000
$19.96 P/Share
|
|
Jan 12
2022
|
Amy E. Tapper Chief, Technical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+4.58%
|
$6,000
$1.52 P/Share
|
|
Jan 12
2022
|
Jennifer Peppe Officer |
SELL
Open market or private sale
|
Direct |
14,000
-8.6%
|
$266,000
$19.95 P/Share
|
|
Jan 12
2022
|
Jennifer Peppe Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,000
+2.83%
|
$14,000
$1.99 P/Share
|
|
Jul 20
2021
|
Omega Fund Vi, L.P. |
BUY
Conversion of derivative security
|
Direct |
2,768,737
+30.72%
|
-
|
|
Jul 20
2021
|
Patrick J Heron Director |
BUY
Conversion of derivative security
|
Indirect |
2,783,774
+27.41%
|
-
|
|
Jul 20
2021
|
Patrick J Heron Director |
BUY
Open market or private purchase
|
Indirect |
187,500
+50.0%
|
$3,000,000
$16.0 P/Share
|
|
Jul 20
2021
|
Clarus Lifesciences Iii, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
150,000
+4.26%
|
$2,400,000
$16.0 P/Share
|
|
Jul 20
2021
|
Clarus Lifesciences Iii, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,225,037
+27.79%
|
-
|
|
Jul 15
2021
|
Robert Baltera Jr. Director |
BUY
Open market or private purchase
|
Indirect |
850
+50.0%
|
$13,600
$16.0 P/Share
|
|
Jul 15
2021
|
Omega Fund Vi, L.P. |
BUY
Open market or private purchase
|
Direct |
250,000
+50.0%
|
$4,000,000
$16.0 P/Share
|